Sanofi: Q3 2012 Business EPS(1) reflects patent expirations

Sanofi: Q3 2012 Business EPS(1) reflects patent expirations
The injunction against sales of PetArmor® Plus remains in effect and the generic product is not on the market. Third-quarter sales of the Production Animals segment were EUR 189 million, up 5.1%, driven by the Veterinary Public Health segment (+46.2%)
Read more on MarketWatch (press release)

Posted in Pet Care Media | Tagged , , , , , , | Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>